| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| SOLENO THERAPEUTICS INC | Chief Development Officer | Common Stock | 20,171 | $933,901 | $46.30 | 21 Jan 2026 | Direct |
| Atara Biotherapeutics, Inc. | EVP, Chief Medical Officer | Common Stock | 171,284 | $66,629 | $0.3890 | 16 Nov 2023 | Direct |
| SOLENO THERAPEUTICS INC | Chief Development Officer | Employee stock option (right to buy) | 4,700 | 21 Jan 2026 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| SLNO | SOLENO THERAPEUTICS INC | 21 Jan 2026 | 2 | $0 | 4 | Chief Development Officer | 23 Jan 2026, 18:04 |
| SLNO | SOLENO THERAPEUTICS INC | 10 Nov 2025 | 2 | $0 | 4 | Chief Development Officer | 12 Nov 2025, 17:21 |
| SLNO | SOLENO THERAPEUTICS INC | 10 Nov 2025 | 0 | $0 | 3 | Chief Development Officer | 12 Nov 2025, 17:19 |
| ATRA | Atara Biotherapeutics, Inc. | 16 Nov 2023 | 1 | -$4,780 | 4 | EVP, Chief Medical Officer | 20 Nov 2023, 17:30 |
| ATRA | Atara Biotherapeutics, Inc. | 16 Aug 2023 | 2 | -$11,526 | 4 | EVP, Chief Medical Officer | 18 Aug 2023, 18:25 |
| ATRA | Atara Biotherapeutics, Inc. | 01 Jun 2023 | 0 | $0 | 3 | EVP, Chief Medical Officer | 09 Jun 2023, 16:30 |